Patent · US Active

Apparatus for treating Benign Prostatic Hyperplasia

US12090136B2 · kind B2 · utility

0Cited by

27References

20Claims

0Family size

Assignee

Resurge Therapeutics, Inc. · US

Inventors

Olof Mikael Trollsas · San Jose, US
John Stankus · Plano, US
Shahram Shawn Gholami · Monte Sereno, US

Key dates

Filing date	Dec 4, 2023
Grant date	Sep 17, 2024
Priority date	—
Expiry date	Dec 4, 2043

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Minimally invasive treatment methods for benign prostatic hyperplasia (BPH) tissue. A system includes a sustained release formulation comprising a cytostatic or cytotoxic drug, and an applicator or delivery system for local delivery of a composition comprising or consisting essentially of the sustained release formulation to the prostate. The applicator containing the composition is characterized by a KIR value of between 40 and 400 Centipoise per unit area.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.